Stay updated on KeyLargo: Pembrolizumab Combo in Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the KeyLargo: Pembrolizumab Combo in Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the KeyLargo: Pembrolizumab Combo in Gastric Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision label updated to v3.5.0, replacing v3.4.3. No study details or user-facing content appear to be altered.
    Difference
    0.1%
    Check dated 2026-03-18T19:56:37.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T17:59:29.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Gastric cancer is added as a related MedlinePlus topic and the Genetic and Rare Diseases Information Center is referenced in the Resources section.
    Difference
    0.2%
    Check dated 2026-02-18T07:14:23.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the site. The previous notice about government funding lapses and the earlier Revision: v3.4.1 text were removed.
    Difference
    0.4%
    Check dated 2026-02-11T06:24:32.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Added a government funding notice banner and a version update to v3.4.1 (removing v3.4.0). These are administrative site changes and do not affect the study content, eligibility, outcomes, or participant information on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T05:13:19.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and updated QC-related labels and revision information (e.g., 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', 'Revision: v3.4.0'); older labels/values (e.g., 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', 'Revision: v3.3.4') were replaced.
    Difference
    0.2%
    Check dated 2026-01-28T03:14:56.000Z thumbnail image

Stay in the know with updates to KeyLargo: Pembrolizumab Combo in Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the KeyLargo: Pembrolizumab Combo in Gastric Cancer Clinical Trial page.